Option Care saw ‘balanced growth’ in Q3
By HME News Staff
Updated 10:07 AM CDT, Thu October 30, 2025
%20(1).jpg)
BANNOCKBURN, Ill. – Option Care Health reported net revenue of $1.435 billion for the third quarter 2025, a 12.2% increase over the same quarter in 2024.
Other financial results for the quarter:
- Gross profit of $272.9 million, up 6.3%
- Net income of $51.8 million, down 3.8%
- Adjusted EBITDA of $119.5 million, up 3.4%
- YTD cash provided by operating activities of $222.6 million
- Repurchased $62.5 million of stock in the quarter
- Term loan expanded $49.6 million, and interest rate reduced
“The Option Care Health team delivered another strong quarter with balanced growth across the portfolio,” said John C. Rademacher, CEO. “I’d like to thank our team for their extraordinary execution and continued dedication to providing access to quality care to more patients. We are well positioned for success as we continue to navigate a dynamic regulatory environment, changing competitive landscapes, and our evolving portfolio of therapies while always keeping the patient at the center of everything we do.”
For the full year 2025, Option Care Health now expects to generate:
- Net revenue of $5.60 billion to $5.65 billion
- Adjusted diluted earnings per share of $1.68 to $1.72
- Adjusted EBITDA of $468 million to $473 million
- Cash flow from operations of at least $320 million
- Effective tax rate of 25% to 27%
- Net interest expense of approximately $55 million to $57 million
Comments